1. Home
  2. Directory
  3. Louisiana
  4. Lafayette
  5. Orthopaedic Surgery
  6. NPI Profile
  7. Prescriptions 1720006687

DR. PAUL E FENN JR. M.D.
Prescription History 1720006687
Orthopaedic Surgery - Foot and Ankle Surgery in Lafayette, LA

NPI Status: Active since July 18, 2006

Contact Information

105 PATRIOT AVE
SUITE 101
LAFAYETTE, LA
ZIP 70508
Phone: (337) 534-0653
Fax: (337) 534-0658

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. PAUL E FENN JR. M.D., an active Foot and Ankle Surgery specialist practicing in Lafayette, LA. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 71 documented patient claims. Among these therapy options, the most frequently utilized medication is Hydrocodone-Acetaminophen, which accounts for 29 claims alone.

Medication Index

G
H
T
No matching medications currently found on file.

Gabapentin

Generic Formulation: GabapentinSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 16
30-Day Fills 18.0
Days Supply 490
LA State Average Benchmarks
Peer Average Claims120.0
Peer Average 30-Day Fills177.5
Peer Average Days Supply5,199
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 86.7% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $186.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.64

State Avg Cost Per Claim

$16.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 29
30-Day Fills 29.0
Days Supply 577
LA State Average Benchmarks
Peer Average Claims114.0
Peer Average 30-Day Fills114.8
Peer Average Days Supply2,386
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 74.6% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $500.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.27

State Avg Cost Per Claim

$17.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Orthopedic Surgery
Provider Metrics Summary
Total Claims 26
30-Day Fills 26.0
Days Supply 520
LA State Average Benchmarks
Peer Average Claims65.0
Peer Average 30-Day Fills84.6
Peer Average Days Supply2,261
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.0% less volume than the regional standard for practitioners inside LA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $175.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.77

State Avg Cost Per Claim

$11.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. PAUL E FENN JR. M.D. provides transparency into local medical care patterns within Lafayette, LA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Foot and Ankle Surgery** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.